- Home
- OPK vs AUPH Comparison
OPK vs AUPH Comparison
Compare OPK & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- AUPH
- Stock Information
- Founded
- OPK 2007
- AUPH 1993
- Country
- OPK United States
- AUPH Canada
- Employees
- OPK N/A
- AUPH N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- AUPH Health Care
- Exchange
- OPK Nasdaq
- AUPH Nasdaq
- Market Cap
- OPK N/A
- AUPH 1.1B
- IPO Year
- OPK 1995
- AUPH 1999
- Fundamental
- Price
- OPK $1.36
- AUPH $7.59
- Analyst Decision
- OPK Buy
- AUPH Strong Buy
- Analyst Count
- OPK 4
- AUPH 2
- Target Price
- OPK $2.75
- AUPH $11.50
- AVG Volume (30 Days)
- OPK 3.5M
- AUPH 1.6M
- Earning Date
- OPK 08-06-2025
- AUPH 07-31-2025
- Dividend Yield
- OPK N/A
- AUPH N/A
- EPS Growth
- OPK N/A
- AUPH N/A
- EPS
- OPK N/A
- AUPH 0.27
- Revenue
- OPK $689,408,000.00
- AUPH $247,295,000.00
- Revenue This Year
- OPK N/A
- AUPH $12.15
- Revenue Next Year
- OPK $7.80
- AUPH $18.31
- P/E Ratio
- OPK N/A
- AUPH $28.53
- Revenue Growth
- OPK N/A
- AUPH 29.20
- 52 Week Low
- OPK $1.19
- AUPH $5.20
- 52 Week High
- OPK $2.04
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- OPK 56.84
- AUPH 40.36
- Support Level
- OPK $1.26
- AUPH $7.29
- Resistance Level
- OPK $1.36
- AUPH $8.86
- Average True Range (ATR)
- OPK 0.04
- AUPH 0.34
- MACD
- OPK 0.01
- AUPH -0.06
- Stochastic Oscillator
- OPK 92.31
- AUPH 19.37
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.